SCHEMBL19509907

SCHEMBL19509907

CCSSC(C)(C)NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19152803 0.76
SCHEMBL575908 0.69
Fluoride SCHEMBL775647 0.67
SCHEMBL2524103 0.65
SCHEMBL3396995 0.65
SCHEMBL11297283 0.65
SCHEMBL13347878 0.65 TSHR (0.33)
Dimethylamine SCHEMBL6419423 0.64
Dimethylamine SCHEMBL8951940 0.61
SCHEMBL12085988 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026968-A1 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 2023-01-26 US disclosed
US-20220213486-A1 COMPLEMENT COMPONENT iRNA COMPOSITIONS AND METHODS OF USE THEREOF ALNYLAM PHARMACEUTICALS, INC. 2022-07-07 US disclosed
US-20210169915-A1 POLYNUCLEOTIDE AGENTS TARGETING ANGIOTENSINOGEN (AGT) AND METHODS OF USE THEREOF WILMINGTON TRUST, NATIONAL ASSOCIATION 2021-06-10 US disclosed
US-10478500-B2 Compositions and methods for inhibition of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) gene expression ALNYLAM PHARMACEUTICALS, INC. (US) 2019-11-19 US disclosed
US-20180169129-A1 POLYNUCLEOTIDE AGENTS TARGETING ANGIOTENSINOGEN (AGT) AND METHODS OF USE THEREOF WILMINGTON TRUST, NATIONAL ASSOCIATION 2018-06-21 US disclosed
US-20170304446-A1 Compositions and Methods for Inhibition of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) Gene Expression BANK OF AMERICA, N.A. 2017-10-26 US disclosed